Lenvatinib Mesylate Intermediate CAS 205448-65-3 Purity >98.0% (HPLC) Factory
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates With High Pure
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene)-2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Ingoa matū | Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate |
Nga kupu taurite | 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib Intermediate 3 |
Tau CAS | 205448-65-3 |
Tau CAT | RF-PI1973 |
Tūnga Taonga | I roto i te Raarangi, Whakaputa Raahanga 50 MT / Tau |
Tātai rāpoi | C12H11NO4 |
Taumaha rāpoi | 233.22 |
Kohuatanga | 421.0±45.0℃ |
Kiato | 1.267±0.060 g/cm3 |
Waitohu | Ruifu Chemical |
Tūemi | Whakatakotoranga |
Te ahua | Paura-White ki te Paura Kowhai |
Te Maama / Tikanga Tatauria | >98.0% (HPLC) |
Ngaronga i te whakamaroke | <1.00% |
Te toenga i runga i te mura | <0.50% |
Nga poke katoa | <2.00% |
H-NMR | He rite ki te Hanganga |
Paerewa Whakamatau | Paerewa hinonga |
Whakamahinga | Takawaenga Rongoa |
Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko
Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku
Ko te Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) he takawaenga o Lenvatinib Mesylate (CAS: 857890-39-2).Ko Lenvatinib, i hokona i raro i te ingoa waitohu Lenvima i roto i etahi atu, he rongoa mo te mate pukupuku mo te maimoatanga o etahi momo mate pukupuku thyroid me etahi atu mate pukupuku ano hoki.I whakawhanakehia e Eisai Co. me te mahi hei aukati kinase maha ki nga kinase VEGFR1, VEGFR2 me VEGFR3.Kua whakaaetia a Lenvatinib (mai i te tau 2015) mo te maimoatanga o te mate pukupuku thyroid rerekee kei te takiwa o te rohe, te metastatic ranei, te ahu whakamua, me te kore e aro ki te maimoatanga me te iodine radioactive (radioiodine).I te marama o Haratua 2016, i whakaaetia e te US Food and Drug Administration (FDA) (i te whakakotahitanga me te everolimus) mo te maimoatanga o te mate pukupuku o te tinana o te renal cell i muri i tetahi o mua o te rongoa anti-angiogenic.Ka whakaaetia ano te rongoa i roto i te US me te Kotahitanga o Europi mo te mate pukupuku hepatocellular e kore e taea te tango ma te pokanga i nga turoro kaore ano kia whiwhi rongoa mate pukupuku ma te waha, ma te werohia ranei.